Pet Veterinary Drug Market
Pet Veterinary Drug Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Pet Veterinary Drug Market Size and Growth
The Pet Veterinary Drug market is experiencing robust growth, driven by rising pet ownership and increasing awareness of animal health. The market size is projected to exceed $12 billion by 2025. Enhanced focus on preventive care and advancements in drug formulations further contribute to favorable market conditions and expansion opportunities. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Boehringer Ingelheim International GmbH
◍ Zoetis Animal Healthcare
◍ Bayer AG
◍ Merck Animal Health
◍ Elanco Animal Health Inc.
◍ Virbac Group
◍ Ceva
◍ Dechra Pharmaceuticals Plc
◍ Vetoquinol
◍ Orion Corporation
The Pet Veterinary Drug Market features major players like Boehringer Ingelheim, Zoetis, Bayer, Merck, Elanco, Virbac, Ceva, Dechra, Vetoquinol, and Orion. These companies drive market growth through innovative product development, strategic partnerships, and expanding distribution networks, significantly boosting sales and enhancing pet healthcare outcomes.
- Zoetis: Approximately $8 billion in revenue.
- Elanco: Around $3 billion in revenue.
- Merck Animal Health: Approximately $4.5 billion in revenue.
- Bayer Animal Health: Roughly $1.5 billion in revenue.
- Boehringer Ingelheim: Estimated $2 billion in revenue from animal health.
Request Sample Report
Market Segmentation
By Application
By Product
Others ◍ Veterinary Hospitals ◍ Veterinary Clinics ◍ Drug Stores
◍ Anti-Infectives
◍ Anti-Inflammatory ◍ Parasiticides ◍ Analgesics
Sedatives
Request Sample Report
12060.00 Million
Request Sample Report
